Categories: News

Kerr Introduces SimpliShade Self-Adhesive Flow

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

A Self-Adhering Composite

BREA, CA / ACCESSWIRE / October 7, 2024 / Kerr Dental is proud to introduce SimpliShade™ Self-Adhesive Flow. Formerly Vertise™ Flow, SimpliShade™ Self-Adhesive Flow eliminates the need for a separate bonding protocol, streamlining the restorative process for dental professionals. This innovative product incorporates Kerr’s renowned OptiBond™ adhesive technology, ensuring high bond strengths to both dentin and enamel.

SimpliShade Self-Adhesive Flow Syringe
SimpliShade Self-Adhesive Flow Syringe

SimpliShade™ Self-Adhesive Flow leverages the adhesive technology found in Kerr’s OptiBond products, creating proven bonds to tooth structure. The composite bonds chemically through the phosphate functional groups of a GPDM monomer and calcium ions of the tooth and micromechanically through an inter-penetrating network formed between polymerized monomers and collagen fibers.

SimpliShade Self-Adhesive Flow incorporates a simplified shade range of Light, Medium, and Dark to match most classic VITA® Shades. In addition to simplified shade matching, by incorporating an adhesive directly into the composite, eliminating the need for a separate bonding agent, this product can help dental practices save on inventory costs.

Exhibiting the same characteristics inherent in self-etch materials, SimpliShade Self-Adhesive flow also greatly reduces the change of post-op sensitivity and has a high radiopacity, making it easily detectable on x-rays.

“One of the most innovative products to appear on the market in quite some time. Its versatility allows for use in multiple indications, saving chair time for the clinician while creating a better experience for the patient,” says Dr. Stephen D. Poss.

SimpliShade Self-Adhesive Flow is now available. To learn more and schedule a demo, visit https://www.kerrdental.com/kerr-restoratives/simplishade-self-adhesive-flow-composites.

# # #

About Kerr Dental

Kerr designs and manufactures products for all aspects of modern restorative dentistry. Our knowledgeable field service works closely with a network of exclusive stockists to provide technical training and support; this strengthens our position as world market leader. We have advanced aesthetic dentistry through education and sustainable solutions based on ideas from the real world, and the Kerr name is now synonymous with integrity among dentists worldwide. Kerr Dental is an operating company of Envista Holdings Corporation. Envista is a global family of more than 30 trusted dental brands. Learn more at kerrdental.com.

Dr. Stephen D. Poss is not a paid consultant of Kerr. The opinions and techniques expressed are those of the doctor. Kerr is a medical device manufacturer and does not dispense medical advice. Clinicians should use their own professional judgment.

Contact Information

Chelsie Keeler
Marketing Manager
chelsie.keeler@envistaco.com
7146288516

SOURCE: Kerr Dental

View the original press release on newswire.com.

Staff

Recent Posts

Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

2 hours ago

HCA Healthcare Reports Second Quarter 2025 Results

Raises 2025 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results…

2 hours ago

Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results

Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of…

2 hours ago

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO),…

5 hours ago

Phio Pharmaceuticals Announces Pathology Results for Four of Five Patients in Fourth Cohort

Complete Pathologic Response in patient with cutaneous squamous cell carcinoma Partial Response in Stage 4…

7 hours ago

Healthcare Analytical Testing Services Market worth $12.48 billion by 2030 with 10.8% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 25, 2025 /PRNewswire/ -- The global Healthcare Analytical Testing Services Market,…

8 hours ago